I had the opportunity to speak with the CEO of SkinBioTherapeutics Plc (SBTX) after market hours on Friday. I was keen to speak to Stuart Ashman about the company's consumer study announced to the market on Wednesday.
The results of the consumer study focussed on Psoriasis, not other psoriatic conditions. These include;
eczema
psoriasis
acne
rosacea
*psoriatβ¦